Journal
RESPIRATORY MEDICINE CASE REPORTS
Volume 28, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.rmcr.2019.100899
Keywords
Benralizumab; Mepolizumab; Severe asthma; Eosinophil
Categories
Ask authors/readers for more resources
We described three severe asthmatics whose asthma symptoms were rapidly improved by benralizumab following favorable response to mepolizumab. Benralizumab-induced eosinophil depletion contributed to clinical improvement of severe asthma after mepolizumab-induced eosinophil reduction; thus, prior favorable responses to mepolizumab may predict benralizumab efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available